Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Non-small Cell Carcinoma × osimertinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 NSCLC 3 Carcinoma 3 Neoplasm Metastasis 2 Lung Neoplasms 2 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Non-small Cell Carcinoma 1 Neoplasms 1 Neoplasm, Residual 1 NSCLC Patients With Brain Metastasis 1 Locally Advanced or Metastatic Non-squamous NSCLC 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Bronchial Neoplasms 1 Brain Neoplasms 1 Anticancer Treatment 1

Interventions

osimertinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695925 2025-10-15

TOP

Sun Yat-sen University

Phase 3 Active not recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡